Showing results (71-80 of 109) with videos related to
Sort By:
Pageof 11
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 1, 1996
[Probability of vaccine therapy for pancreas cancer]M Takahashi, S Togou, H Yamaoka, et al.The Journal of Urology|October 12, 2000
Antibody immunity to prostate cancer associated antigens can be detected in the serum of patients with prostate cancerD G McNeel, L D Nguyen, B E Storer, et al.Proceedings of the National Academy of Sciences of the United States of America|February 15, 1992
T-cell immunity to the joining region of p210BCR-ABL proteinW Chen, D J Peace, D K Rovira, et al.Pediatric Research|May 1, 1986
Circulating immune complexes in cystic fibrosis and their correlation to clinical parametersM L Disis, T L McDonald, J L Colombo, et al.The Prostate|May 15, 2001
Naturally occurring prostate cancer antigen-specific T cell responses of a Th1 phenotype can be detected in patients with prostate cancerD G McNeel, L D Nguyen, W J Ellis, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1988
IL-4-induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytesD J Peace, D E Kern, K R Schultz, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1988
Il-4 is an endogenous T cell growth factor during the immune response to a syngeneic retrovirus-induced tumorD E Kern, D J Peace, J P Klarnet, et al.Cancer|September 1, 1981
High-dose combination chemotherapy for acute nonlymphoblastic leukemia in adultsH Glucksberg, M A Cheever, V T Farewell, et al.Cancer Treatment Reports|June 1, 1982
Treatment of refractory acute nonlymphocytic leukemia with a combination of pyrazofurin and cytarabineH G Kaplan, F R Appelbaum, M A Cheever, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 9, 2021
Therapeutic cancer vaccines revamping: technology advancements and pitfallsG Antonarelli, C Corti, P Tarantino, et al.Pageof 11